Kato Seiichi, Ozawa Kyoko, Okuda Masumi, Fujisawa Takuji, Kagimoto Seiichi, Konno Mutsuko, Maisawa Shunichi, Iinuma Kazuie
Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan.
Am J Gastroenterol. 2003 Feb;98(2):296-300. doi: 10.1111/j.1572-0241.2003.07263.x.
The (13)C-urea breath test (UBT) has been accepted as a reliable noninvasive test for detecting Helicobacter pylori infection. Recently, another noninvasive test, a new enzyme immunoassay for H. pylori antigens in stool, has been widely investigated for its clinical usefulness. The purpose of this multicenter study was to evaluate the diagnostic accuracy of the stool antigen test in Japanese children.
A total of 264 children (148 male and 116 female; mean age 9.2 yr, range 2-17 yr) who underwent (13)C-UBT and the stool antigen test were studied. The diagnosis in these patients was gastritis (n = 49), gastric ulcer (n = 4), duodenal ulcer (n = 24), recurrent abdominal pain (n = 43), and other conditions (n = 144). The stool antigen test was performed using the HpSA ELISA (Premier Platinum HpSA, Meridian Diagnostics). According to manufacturer's instructions, an absorbance at 450/630 nm of <0.100, > or =0.120, and 0.100-0.119 was defined as negative, positive, and indeterminate, respectively. Based on the (13)C-UBT with a cutoff value of 3.5 per mil, the performance of HpSA was studied. In 21 patients who received eradication therapy, the HpSA was performed at baseline and at 1, 2, and 6 months after completion of therapy. Eradication of H. pylori was confirmed by (13)C-UBT at 2 or 3 months of follow-up.
(13)C-UBT showed that 76 children were infected with H. pylori and 188 were not infected. In these same children, HpSA results were positive in 77 children, negative in 183, and indeterminate in four. The overall sensitivity, specificity, and accuracy of the test were 96.0% (95% CI = 88.6-99.2%), 96.8% (95% CI = 94.2-99.3%), and 96.5% (95% CI = 94.3-98.8%), respectively. There were no significant differences in these results among age groups of < or =5, 6-10, and > or =11 yr. Receiver operating characteristic curve analysis demonstrated that the best cutoff value of absorbance at 450/630 nm was 0.110. When a single cutoff value of 0.110 without indeterminate results was used, the sensitivity, specificity, and accuracy were 96.1% (95% CI = 90.8-99.7%), 96.3% (95% CI = 93.6-99.0%), and 96.2% (95% CI = 93.9-98.5%), respectively. In 19 patients in whom H. pylori was successfully eradicated, HpSA results were negative at 1 month of follow-up and remained negative through 6 months.
The HpSA is an accurate test for the detection of H. pylori infection in all age groups of children.
碳-13尿素呼气试验(UBT)已被公认为检测幽门螺杆菌感染的可靠非侵入性检测方法。最近,另一种非侵入性检测方法,即一种用于检测粪便中幽门螺杆菌抗原的新型酶免疫测定法,已被广泛研究其临床实用性。这项多中心研究的目的是评估粪便抗原检测在日本儿童中的诊断准确性。
对264名接受碳-13 UBT和粪便抗原检测的儿童(148名男性和116名女性;平均年龄9.2岁,范围2至17岁)进行了研究。这些患者的诊断为胃炎(n = 49)、胃溃疡(n = 4)、十二指肠溃疡(n = 24)、复发性腹痛(n = 43)和其他病症(n = 144)。粪便抗原检测使用HpSA ELISA(Premier Platinum HpSA,Meridian Diagnostics)进行。根据制造商的说明,450/630 nm处的吸光度<0.100、≥0.120和0.100至0.119分别定义为阴性、阳性和不确定。基于碳-13 UBT的临界值为3.5‰,研究了HpSA的性能。在21名接受根除治疗的患者中,在基线时以及治疗完成后1、2和6个月进行了HpSA检测。在随访的2或3个月时通过碳-13 UBT确认幽门螺杆菌的根除情况。
碳-13 UBT显示76名儿童感染了幽门螺杆菌,188名未感染。在这些相同的儿童中,HpSA结果在77名儿童中为阳性,183名中为阴性,4名中为不确定。该检测的总体敏感性、特异性和准确性分别为96.0%(95% CI = 88.6 - 99.2%)、96.8%(95% CI = 94.2 - 99.3%)和96.5%(95% CI = 94.3 - 98.8%)。在≤5岁、6至10岁和≥11岁的年龄组中,这些结果没有显著差异。受试者工作特征曲线分析表明,450/630 nm处吸光度的最佳临界值为0.110。当使用单一临界值0.110且无不确定结果时,敏感性、特异性和准确性分别为96.1%(95% CI = 90.8 - 99.7%)、96.3%(95% CI = 93.6 - 99.0%)和96.2%(95% CI = 93.9 - 98.5%)。在19名成功根除幽门螺杆菌的患者中,随访1个月时HpSA结果为阴性,并在6个月内一直保持阴性。
HpSA是检测所有年龄组儿童幽门螺杆菌感染的准确检测方法。